File S1 - KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan

Table S1, Sensitivity, specificity, and predictive values of IL28B TT genotype and KIR3DL1/HLA-Bw4 or KIR2DL2/HLA-C1 for a sustained virological response in 115 patients with chronic hepatitis C. Data are expressed as % (n). PPV, positive predictive value; NPV, negative predictive value. Table S2, Frequency of IL28B genotype and KIR3DL1/HLA-Bw4 and KIR2DL2/HLA-C1 combinations in 56 patients with a sustained virological response (SVR) and 59 patients with a non-SVR to pegylated interferon and ribavirin therapy of chronic hepatitis C. Data are expressed as n (%). (DOC)